Our Pipeline

First in Class Neutrophil Modifying Drug Candidates

Neutrophil Drug Manipulation
Program Discovery Target Validation In Vivo POC Lead Selection CMC In Vivo CRO Pre-IND
IMYX-3 RESPIRATORY
Q4 2022
IMYX-4 INFLAMMATORY
IMYX-5 CANCER
Q4 2023
Neutrophil Genomic Manipulation
Program Discovery Target Validation In Vivo POC Lead Selection CMC In Vivo CRO Pre-IND
IMYX-LNP mRNA1
Q4 2022
IMYX-LNP siRNA2